1 |
McNicol, A. and Shibou, T. S. (1998) Translocation and phosphorylation of cytosolic phospholipase A2 in activated platelets. Thromb. Res. 92: 19-26.
DOI
|
2 |
Chuang, W. Y., Kung, P. H., Kuo, C. Y. and Wu, C. C. (2013) Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway. Thromb. Haemost. 109: 1120-1130.
DOI
|
3 |
Ali, M. Y., Jannat, S., Jung, H. A., Choi, R. J., Roy, A. and Choi, J. S. (2016) Anti-Alzheimer's disease potential of coumarins from Angelica decursiva and Artemisia capillaris and structure-activity analysis. Asian. Pac. J. Trop. Med. 9: 103-111.
DOI
|
4 |
Dong, J., Yuan, J., Wang, J. L., Ji, R. F., Quan, Q. H., Guo, X. Y., Gao, J. and Liu, Y. G. (2017) Study on screening antitumor active fractions and chemical components in active fractions from root of Anaycclus pyrethrum. Zhongguo Zhong Yao Za Zhi 42: 3932-3937.
|
5 |
Huang, H. C., Chu, S. H. and Chao, P. D. (1991) Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur. J. Pharmacol. 198: 211-213.
DOI
|
6 |
Huang, H. C., Lee, C. R., Weng, Y. I., Lee, M. C. and Lee, Y. T. (1992) Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. Eur. J. Pharmacol. 218: 123-128.
DOI
|
7 |
Cipollone, F., Patrignani, P., Greco, A., Panara, M. R., Padovano, R., Cuccurullo, F., Patrono, C., Rebuzzi, A. G., Liuzzo, G., Quaranta, G. and Maseri, A. (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 96: 1109-1116.
DOI
|
8 |
Lu, C., Li, Y., Hu, S., Cai, Y., Yang, Z. and Peng, K. (2018) Scoparone prevents IL- -induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF- pathway. Biomed. Pharmacother. 106: 1169-1174.
DOI
|
9 |
Shin, J. H., Kwon, H. W. and Lee, D. H. (2019) Ginsenoside F4 inhibits platelet aggregation and thrombus formation by dephosphorylation of IP3RI and VASP. J. Appl. Biol. Chem. 62: 93-100.
DOI
|
10 |
Chang, M. C., Wang, T. M., Yeung, S. Y., Jeng, P. Y., Liao, C. H., Lin, C. C., Lin, B. R. and Jeng, J. H. (2011) Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Atherosclerosis 219: 559-565.
DOI
|
11 |
Patrono, C. (2001) Aspirin: new cardiovascular uses for an old drug. Am. J. Med. 110: 62S-65S.
DOI
|
12 |
Lee, D. H. (2020) Inhibitory effects of scoparone through regulation of PI3K/Akt and MAPK on collagen-induced human platelets. J. Appl. Biol. Chem. 63: 131-136.
DOI
|
13 |
Irfan, M., Jeong, D., Saba, E., Kwon, H. W., Shin, J. H., Jeon, B. R., Kim, S., Kim, S. D., Lee, D. H., Nah, S. Y. and Rhee, M. H. (2019) Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling. Platelets 30: 589-598.
DOI
|
14 |
McNicol, A. and Jackson, E. C. (2003) Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem. Pharmacol. 65: 1243-1250.
DOI
|
15 |
Sabatine, M. S. and Jang, I. K. (2000) The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am. J. Med. 109: 224-237.
DOI
|
16 |
Jackson, S. P. (2011) Arterial thrombosis?insidious, unpredictable and deadly. Nat. Med. 17: 1423-1436.
DOI
|
17 |
Schwartz, S. M., Heimark, R. L. and Majesky, M. W. (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70: 1177-1209.
DOI
|
18 |
Payrastre, B., Missy, K., Trumel, C., Bodin, S., Plantavid, M. and Chap, H. (2000) The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem. Pharmacol. 60: 1069-1074.
DOI
|
19 |
Morello, F., Perino, A. and Hirsch, E. (2009) Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc. Res. 82: 261-271.
DOI
|
20 |
Jennings, L. K. (2009) Role of platelets in atherothrombosis. Am. J. Cardiol. 103: 4A-10A.
DOI
|
21 |
Cattanco, M., Tenconi, P. M., Lecchi, A. and Mannucci, P. M. (1991) In vitro effects of picotamide on human platelet aggregation, the release re- action and thromboxane B2 production. Thromb. Res. 62: 717-724.
DOI
|
22 |
Su, C. Y., Shiao, M. S. and Wang, C. T. (1999) Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Biochem. Pharmacol. 58: 587-595.
DOI
|
23 |
Flevaris, P., Li, Z., Zhang, G., Zheng, Y., Liu, J. and Du, X. (2009) Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 113: 893-901.
DOI
|
24 |
Adam, F., Kauskot, A., Rosa, J. P. and Bryckaert, M. (2008) Mitogenactivated protein kinases in hemostasis and thrombosis. J. Thromb. Haemost. 6: 2007-2016.
DOI
|
25 |
Bugaud, F., Nadal-Wollbold, F., Levy-Toledano, S., Rosa, J. P. and Bryckaert, M. (1990) Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 94: 3800-3805.
DOI
|
26 |
Kramer, R. M., Roberts, E. F., Strifler, B. A. and Johnstone, E. M. (1995) Thrombin induces activation of p38 MAP kinase in human platelets. J. Biol. Chem. 270: 27395-27398.
DOI
|
27 |
Nadal-Wollbold, F., Pawlowski, M., Levy-Toledano, S., Berrou, E., Rosa, J. P. and Bryckaert, M. (2002) Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett. 531: 475-482.
DOI
|
28 |
Patrono, C. (1994) Aspirin as an antiplatelet drug. N. Engl. J. Med. 330: 1287-1294.
DOI
|
29 |
Kramer, R. M., Roberts, E. F., Um, S. L., Borsch-Haubold, A. G., Watson, S. P., Fisher, M. J. and Jakubowski, J. A. (1996) p38 mitogenactivated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem. 271: 27723-27729.
DOI
|